Press Releases about Ensysce Biosciences Inc![]() ![]()
Ensysce Biosciences Regains Compliance with Nasdaq
May 28, 2024
Via ACCESSWIRE
![]() ![]() ![]() ![]() ![]() ![]() Via ACCESSWIRE
![]() ![]()
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
February 27, 2024
Via ACCESSWIRE
![]() ![]() ![]() ![]() ![]()
Ensysce Biosciences Announces Key Efficacy Data for Lead Analgesic
December 14, 2023
Via ACCESSWIRE
![]() ![]() ![]()
Ensysce Biosciences Issues 2024 Shareholder Letter
January 08, 2024
Via ACCESSWIRE
![]()
Ensysce Biosciences Postpones Special Meeting of Stockholders to December 29, 2023
December 19, 2023
Via ACCESSWIRE
![]() ![]() ![]() Via ACCESSWIRE
![]()
Ensysce Biosciences Reports Third Quarter 2023 Financial Results
November 09, 2023
Via ACCESSWIRE
![]()
Ensysce Biosciences Secures $1.7 Million Convertible Note Financing
October 24, 2023
Via ACCESSWIRE
![]() ![]() Via ACCESSWIRE
![]() Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|